original ) (raw )Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases
Edoardo Lanino
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017
View PDFchevron_right
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency
Petr Sedlacek , Morton Cowan
Journal of Allergy and Clinical Immunology, 2014
View PDFchevron_right
Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects
Morton Cowan
Journal of Allergy and Clinical Immunology, 2013
View PDFchevron_right
Transplantation outcomes for severe combined immunodeficiency, 2000-2009
Elie Haddad
The New England journal of medicine, 2014
View PDFchevron_right
[Survival analysis of hematopoietic stem cell transplantation in children with primary immunodeficiency in Spain]
Isabel Badell
Anales de pediatría (Barcelona, Spain : 2003), 2015
View PDFchevron_right
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders
Emel Ozyurek
Bone Marrow Transplantation, 2008
View PDFchevron_right
Transplant Outcomes for Primary Immunodeficiency Disease
Angela Smith
Seminars in Hematology, 2010
View PDFchevron_right
Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)
Frederick Goldman
Biology of Blood and Marrow Transplantation, 2020
View PDFchevron_right
Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team
Masayuki Nagasawa
Bone Marrow Transplantation, 2006
View PDFchevron_right
Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation
Joanna Zawitkowska
In Vivo
View PDFchevron_right
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience
Reem Elfeky
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017
View PDFchevron_right
Long term outcomes of severe combined immunodeficiency: therapy implications
Morton Cowan
Expert Review of Clinical Immunology, 2017
View PDFchevron_right
A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD)
Valerie Brown
Pediatric Transplantation, 2011
View PDFchevron_right
New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies
Ravi Shah
Journal of Allergy and Clinical Immunology, 2019
View PDFchevron_right
Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency (SCID) after Non-Ablative Related Donor Bone Marrow Transplantation
Rebecca Buckley
Journal of Allergy and Clinical Immunology, 2008
View PDFchevron_right
Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies
juan ortega
Bone Marrow Transplantation, 2008
View PDFchevron_right
Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb
Mary Paul
Journal of Allergy and Clinical Immunology, 2008
View PDFchevron_right
Association of early donor chimerism status with survival outcomes in post allogeneic hematopoietic stem cell transplant patients of nonmalignant diseases
Nadir Ali
Journal of the Pakistan Medical Association, 2021
View PDFchevron_right
Impact of Genetic Diagnosis on the Outcome of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Disorders
Morton Cowan
Journal of Clinical Immunology, 2022
View PDFchevron_right
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning
Wiliam Shearer
Journal of Allergy and Clinical Immunology, 2009
View PDFchevron_right
Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants
Juan Ortega
Bone Marrow Transplantation, 1999
View PDFchevron_right
Matched unrelated bone marrow transplant for severe combined immunodeficiency
Ilan Dalal
Immunologic Research, 2007
View PDFchevron_right
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen
Kejian Zhang
Biology of Blood and Marrow Transplantation, 2015
View PDFchevron_right
T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency
Donald Kohn
Archivum Immunologiae et Therapiae Experimentalis
View PDFchevron_right
Successful Matched Sibling Donor Marrow Transplantation Following Reduced Intensity Conditioning in Children with Hemoglobinopathies
Shalini Shenoy
American Journal of Hematology, 2015
View PDFchevron_right
Stem cell transplantation for immunodeficiency
Nada Jabado
Springer Seminars in Immunopathology, 1998
View PDFchevron_right